대한결핵및호흡기학회 KATRDKATRDIC 2021

GNB 메뉴 보기

KATRD 2021 International Conference
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program

Program

Program in Detail

  한국어 진행 강의입니다.
Opening Ceremony
08:20-08:30
Crystal Ballroom 1
08:20-08:30 Opening Address
O Jung Kwon (President, KATRD)
Welcome Address
Jae Jeong Shim (KATRD Chairman of the Board of Trustees, Korea University, Korea)
Plenary Session 1
08:30-10:00
Crystal Ballroom 1
Chairs Jae Jeong Shim (KATRD Chairman of the Board of Trustees, Korea University, Korea)
Hojoong Kim (Sungkyunkwan University, Korea)
08:30-09:00 PS 1-1 Approach and Management of Elderly Lung Cancer Patients in Super-aged Society
Yoichi Nakanishi (APSR President, Kitakyushu City Hospital Organization, Japan)
09:00-09:30 PS 1-2 The Importance of Effective Registries in Pulmonary Diseases and How to Optimize Their Output
Joanna Chorostowska-Wynimko (ERS Secretary General, European Respiratory Society, Poland)
09:30-10:00 PS 1-3 Update of Combined Pulmonary Fibrosis and Emphysema (CPFE)
Vincent Cottin (University of Lyon, France)
Break
10:00-10:30
[Symposium 01]
Airway Disease 1 - Controversies and Perspectives in Airway Diseases
10:30-12:00
Crystal Ballroom 1
Chair Yeon-Mok Oh (University of Ulsan, Korea)
10:30-11:00 SY 1-1 Controversies and Opportunities in Severe Asthma
Marc Humbert (ERS President, Paris-Saclay University, France)
11:00-11:30 SY 1-2 Current Controversies and Future Perspectives in COPD
Bartolome Celli (Harvard Medical School, USA)
11:30-12:00 SY 1-3 The Importance of Real-life Research in Respiratory Medicine
Nicolas Roche (University of Paris, France)
[Symposium 04]
Interstitial Lung Disease 1 - Wide Spectrum of Fibrotic Lung Diseases in Real World
10:30-12:00
Crystal Ballroom 2
Chair Yong Hyun Kim (The Catholic University of Korea, Korea)
10:30-11:00 SY 4-1 Wide Spectrum of Fibrotic Lung Disease in Real World
Vincent Cottin (University of Lyon, France)
11:00-11:30 SY 4-2 Diagnosis and Management of Interstitial Lung Disease in Rheumatoid Arthritis
Vu Van Giap (Viet Nam Respiratory Society (VNRS), Vietnam)
11:30-12:00 SY 4-3 SSc-ILD: Current Evidences and Application
Jong Sun Park (Seoul National University, Korea)
[Symposium 07]
Lung Cancer 1 - New Applicable Biomarkers in Lung Cancer
10:30-12:00
Crystal Ballroom 3
Chair Sei Hoon Yang (Wonkwang University, Korea)
10:30-11:00 SY 7-1 Navigating the Evolving NSCLC 1L Treatment Landscape with a Focus on Nivolumab + Ipilimumab
Satoshi Ikeda (Kanagawa Cardiovascular and Respiratory Center, Japan)
11:00-11:30 SY 7-2 Current Achievement and Future Perspective of Genome Profiling by Liquid Biopsy
Naoko Aragane (Saga University Hospital, Japan)
11:30-12:00 SY 7-3 Imaging Biomarkers in Lung Cancer
Jin Mo Goo (Seoul National University, Korea)
[Symposium 19]
Management of Airway Diseases in Asia
10:30-12:00
Emerald Room
Chair Ho Joo Yoon (Hanyang University, Korea)
10:30-11:00 SY 19-1 Early Detection and Management of COPD
Ching-Hsiung Lin (Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), Taiwan)
11:00-11:30 SY 19-2 Philippine COPD Pathway Project
Bernice Ong-dela Cruz (Philippine College of Chest Physicians (PCCP), Philippines)
11:30-12:00 SY 19-3 Diagnosis and Management of Benign Central Airway Stenosis: Experience from Vietnam
Ngo Quy Chau (VNRS President, Viet Nam Respiratory Society (VNRS), Vietnam)
[Luncheon Symposium 01]
Airway Disease
12:00-12:30
Crystal Ballroom 1
Chair Yun-Seong Kim (Pusan National University, Korea)
12:00-12:30 LS 1 Which Types of Asthma Patients Would Benefit from Omalizumab?
Marc Humbert (ERS President, Paris-Saclay University, France)
[Luncheon Symposium 02]
Interstitial Lung Disease
12:00-12:30
Crystal Ballroom 2
Chair Sung Woo Park (Soon Chun Hyang University, Korea)
12:00-12:30 LS 2 Antifibrotic Therapy in Japan: Long Term Treatment Experience of Pirfenidone
Hirofumi Chiba (Sapporo Medical University, Japan)
[Luncheon Symposium 03]
Lung Cancer
12:00-12:30
Crystal Ballroom 3
Chair Yoon Soo Chang (Yonsei University, Korea)
12:00-12:30 LS 3 Transform Treatment Strategy for EGFRm NSCLC Patients from Early to Advanced Stage
In-Jae Oh (Chonnam National University, Korea)
Break
12:30-13:30
[Symposium 02]
Airway Disease 2 - Current and Future of Using Biomarkers in the Management of Airway Diseases
13:30-15:00
Crystal Ballroom 1
Chair Yong Chul Lee (Jeonbuk National University, Korea)
13:30-14:00 SY 2-1 Blood and Sputum Eosinophil as a Biomarker of COPD
Dave Singh (University of Manchester, UK)
14:00-14:30 SY 2-2 Biomarkers and Biologics for Severe Asthma
Klaus F. Rabe (German Center for Lung Research (DZL), Germany)
14:30-15:00 SY 2-3 Multi-Omics Based Precision Medicine in Asthma
Tae-Bum Kim (University of Ulsan, Korea)
[Symposium 05]
Interstitial Lung Disease 2 - Update of Rare and Orphan Lung Diseases
13:30-15:00
Crystal Ballroom 2
Chair Moo Suk Park (Yonsei University, Korea)
13:30-14:00 SY 5-1 Pulmonary Alveolar Proteinosis: No Longer Orphan in New Era?
Yoshikazu Inoue (National Hospital Organization Kinki-Chuo Chest Medical Center, Japan)
14:00-14:30 SY 5-2 Lymphangioleiomatosis
Yangjin Jegal (Ulsan University, Korea)
14:30-15:00 SY 5-3 Pleuroparenchymal Fibroelastosis (PPFE)
Takafumi Suda (Hamamatsu University School of Medicine, Japan)
[Symposium 08]
Lung Cancer 2 - Additional Treatment: Worthwhile and When
13:30-15:00
Crystal Ballroom 3
Chair Kye Young Lee (Konkuk University, Korea)
13:30-14:00 SY 8-1 Adjuvant Chemotherapy of Completely Resected Stage 1 Non-Small Cell Lung Cancer
Shin Yup Lee (Kyungpook National University, Korea)
14:00-14:30 SY 8-2 Abscopal Effect of Radiotherapy Combined with Immune Checkpoint Inhibitors
Chang Dong Yeo (The Catholic University of Korea, Korea)
14:30-15:00 SY 8-3 Salvage Surgery for Non-Small Cell Lung Cancer After Tyrosine Kinase Inhibitor Treatment
Chaeuk Chung (Chungnam National University, Korea)
Break
15:00-15:30
[Symposium 03]
Environmental Lung Disease - Hot Topics in Environmental Lung Diseases in 2021
15:30-17:00
Crystal Ballroom 1
Chair Sung Hwan Jeong (Gachon University, Korea)
15:30-16:00 SY 3-1 Humidifier Disinfectant (HD) and Bronchial Asthma
Hyoung-Kyu Yoon (The Catholic University of Korea, Korea)
16:00-16:30 SY 3-2 Climate Change and Related Medical Problems
Jun-Pyo Myong (The Catholic University of Korea, Korea)
16:30-17:00 SY 3-3 Changes in Air Pollution during the COVID-19 Pandemic and Related Health Effects
Sun-Young Kim (National Cancer Center, Korea)
[Symposium 06]
Tuberculosis - Beyond the Current Treatment of Tuberculosis
15:30-17:00
Crystal Ballroom 2
Chair Jae Chol Choi (Chung-Ang University, Korea)
15:30-16:00 SY 6-1 Personalized Therapy for TB
Jan Heyckendorf (Research Center Borstel, Germany)
16:00-16:30 SY 6-2 Host-Directed Therapy for Tuberculosis
Nakwon Kwak (Seoul National University, Korea)
16:30-17:00 SY 6-3 TB Co-infection among COVID Confirmed Patients – The Philippine Experience
Jubert Benedicto (Philippine College of Chest Physicians (PCCP), Philippines)
[Symposium 09]
Lung Cancer 3 - Beyond Standard Treatment
15:30-17:00
Crystal Ballroom 3
Chair Seung Joon Kim (The Catholic University of Korea, Korea)
15:30-16:00 SY 9-1 The Emerging Therapeutic Landscape of ALK TKIs in Advanced NSCLC
Herbert Loong (The Chinese University of Hong Kong, Hong Kong)
16:00-16:30 SY 9-2 Immune Checkpoint Inhibitors in NSCLC with Driver Mutations
Seung Yong Park (Jeonbuk National University, Korea)
16:30-17:00 SY 9-3 Management of Brain Metastasis Considering Molecular Profiling
James Chih-Hsin Yang (National Taiwan University Cancer Center, Taiwan)
Break
17:00-17:15
[Satellite Symposium 1]
Airway Disease
17:15-18:15
Crystal Ballroom 1
Chair Joohun Park (Ajou University, Korea)
17:15-17:45 SS 1-1 Why Wouldn’t We Intervene Earlier in Patients at Risk of Exacerbation?
Alberto Papi (University of Ferrara, Italy)
17:45-18:15 SS 1-2 Should You Initiate Treatment with One or Two Bronchodilators?
Claus F. Vogelmeier (University of Marburg, Germany)
[Satellite Symposium 2]
Airway Disease
17:15-17:45
Crystal Ballroom 2
Chair Myung Jae Park (Kyung Hee University, Korea)
17:15-17:45 SS 2 Reconsidering the Potential of Inhaled Therapies in Asthma
Nicolas Roche (University of Paris, France)
[Satellite Symposium 3]
Interstitial Lung Disease / Airway Disease
17:15-18:15
Crystal Ballroom 3
Chair Man Pyo Chung (Sungkyunkwan University, Korea)
17:15-17:45 SS 3-1 Exploring Optimal Treatment Options for Progressive Fibrosing ILDs : How to Treat?
Jin Woo Song (University of Ulsan, Korea)
17:45-18:15 SS 3-2 What Do COPD Real World Studies Tell Us about LAMA/LABA Initiation in Maintenance Therapy?
Jennifer Quint (Imperial College London, UK)

Go Top

© The Korean Academy of Tuberculosis and Respiratory Diseases

Contact Secretariat of KATRDIC 2021
P&M  MS Bldg. 12, Eonju-ro 79-gil, Gangnam-gu, Seoul 06222, Korea